Current therapies for scarring are limited. New directions for reduction in scarring come from insights gained from mucosal healing and fetal healing where scarring is limited. This session will explore recent investigational and clinical approaches, including a review of clinical trials with basis for mechanism of action.
Wound care practitioners frequently advocate for the concept of interdisciplinary care for wound patients, but may not recognize the benefits of including a physical therapist (PT) on the wound care team. As rehabilitation specialists, PTs are acutely aware of returning individuals to functional independence and facilitating wound repair can be critical in this process. This session will focus on how PTs engage in wound care from the operation of outpatient PT-based wound care clinics to comprehensive inpatient acute and rehabilitation facilities. Adjunctive devices that promote edema reduction, pressure modification, reduce bioburden, and facilitate repair and function will be discussed along with the PTs role in more traditional forms of wound management
Limb regeneration, which is virtually absent in adult humans, is a tantalizing capability that several other species have retained. While a salamander can regrow an arm, we can at best grow a new fingertip. Loss of limbs from trauma and disease could be solved in two ways: understanding the signals and processes that limit and promote limb regeneration, or construct a bionic limb equivalent that is highly integrated with the patient’s nervous system.
Returning for the second year, this popular session will select common wound care practices to be scrutinized in the light of research data. Five myths in wound care practices will be analyzed in terms of existing research supporting the practice, origins of the practice, public policy related to the practice, and/or clinical practice guidelines/expert opinion surrounding the practice. The session will conclude with “4 Out the Door,” four key research areas that have strong clinical implications for clinicians.
Understanding how the wound environment can influence biofilm formation is essential in the development of effective therapeutic agents. Over the years, various therapies have been tried to combat biofilms and reduce their ability to form. The focus of this session is review the basic biochemistry of biofilms, how they can be manipulated in the wound care setting and present the evidence of current therapies, e.g. quorum sensing blockers, debridement, antimicrobials, dressings, lactoferrin, antimicrobial peptides, nitric oxide, etc. In addition, a better understanding of how bacterial virulence is related to biofilm presence will be discussed.
Cell-based therapy has a well-established place in the treatment of chronic wounds. Currently, these therapies employ differentiated cells such as keratinocytes or fibroblasts. It is likely that one of the first areas for mainstream application of stem cells and regenerative medicine will be in non-healing wounds. This session will review the state of the art and potential breakthrough technologies, including embryonic, induced pluripotent, bone marrow, and tissue-derived stem cells.
Clinicians are often challenged with slow-healing wounds, or wounds that simply fail to heal. In this SAWC staple program, a panel of clinicians and scientists will examine real cases and provide strategies for discovering the barriers to healing, as well as provide potential interventions to overcome these barriers.
Continuing the theme of Wound Scene Investigation 1, a panel of clinicians and scientists will examine real cases and provide strategies for discovering the barriers to healing, as well as provide potential interventions to overcome these barriers.